Medicare Enrolled

Dr. Mary Davidian, MD

Ophthalmology · New Windsor, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
140 EXECUTIVE DR, New Windsor, NY 12553
8455620138
In practice since 2005 (20 years)
NPI: 1780683052 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Davidian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Davidian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Davidian

Dr. Mary Davidian is an ophthalmology specialist in New Windsor, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Davidian performed 2,263 Medicare services across 1,925 unique beneficiaries.

Between the years covered by Open Payments, Dr. Davidian received a total of $36,375 from 45 pharmaceutical and/or device companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Davidian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 43% volume in NY $36,375 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,263
Medicare services
Top 43% in NY for ophthalmology
1,925
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
453 $94 $175
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
265 $34 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
234 $69 $125
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
231 $31 $250
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
215 $69 $125
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
186 $447 $3,031
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
120 $27 $80
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
117 $26 $248
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
97 $120 $200
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
88 $46 $148
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
77 $278 $2,000
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
58 $26 $250
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
30 $20 $100
Eye photography
Photographic imaging of the interior structures of the eye.
29 $20 $51
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
19 $9 $50
Complex cataract removal with lens implant
A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision.
18 $614 $4,000
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
14 $65 $150
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
12 $93 $175
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
21.5% medium
70.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$36,375
Total received (2018-2024)
Avg $5,196/year across 7 years
Top 4% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
455
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,382 (50.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,045 (35.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,948 (13.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,964
2023
$6,865
2022
$2,419
2021
$6,218
2020
$557
2019
$9,484
2018
$6,867

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BIOTISSUE HOLDINGS INC.
$1,587
LENSAR, Inc.
$428
ABBVIE INC.
$400
Bausch & Lomb Americas Inc.
$232
Harrow Eye, LLC
$202
Alcon Vision LLC
$173
Dompe US, Inc.
$166
Mallinckrodt Hospital Products Inc.
$139
Oyster Point Pharma, Inc.
$134
Tarsus Pharmaceuticals, Inc.
$127
SUN PHARMACEUTICAL INDUSTRIES INC.
$119
Sight Sciences, Inc.
$76
Carl Zeiss Meditec USA, Inc.
$43
Rayner Intraocular Lenses Limited
$31
Glaukos Corporation
$30
Amgen Inc.
$27
CooperVision Inc.
$25
ANI Pharmaceuticals, Inc.
$25
Top 3 companies account for 60.9% of 2024 payments
All-time payments by company (2018-2024) ›
Dompe US, Inc.
$14,218
TissueTech, Inc.
$5,469
Shire North American Group Inc
$5,267
BIOTISSUE HOLDINGS INC.
$1,587
Alcon Vision LLC
$1,036
Sun Pharmaceutical Industries Inc.
$760
Sight Sciences, Inc.
$675
ABBVIE INC.
$604
Oyster Point Pharma, Inc.
$528
Mallinckrodt Hospital Products Inc.
$508
Aerie Pharmaceuticals, Inc.
$472
Bausch & Lomb, a division of Bausch Health US, LLC
$457
LENSAR, Inc.
$428
Novartis Pharmaceuticals Corporation
$406
Allergan Inc.
$404
Bausch & Lomb Americas Inc.
$335
Johnson & Johnson Surgical Vision, Inc.
$319
Allergan, Inc.
$305
Kala Pharmaceuticals, Inc.
$280
AbbVie Inc.
$235
SUN PHARMACEUTICAL INDUSTRIES INC.
$220
Harrow Eye, LLC
$202
EyePoint Pharmaceuticals US, Inc.
$181
BIOTISSUE HOLDINGS, INC.
$176
Horizon Therapeutics plc
$157
Tarsus Pharmaceuticals, Inc.
$127
BioTissue Holdings, Inc.
$123
NEW WORLD MEDICAL,INC.
$112
Eyevance Pharmaceuticals LLC
$97
Iridex Corporation
$81
RxSight Inc
$78
Mallinckrodt LLC
$76
ANI Pharmaceuticals, Inc.
$56
Alcon Laboratories Inc
$51
Omeros Corporation
$49
Carl Zeiss Meditec USA, Inc.
$43
TISSUETECH, INC.
$41
Mallinckrodt Enterprises LLC
$33
Rayner Intraocular Lenses Limited
$31
Glaukos Corporation
$30
Amgen Inc.
$27
CooperVision Inc.
$25
Ocular Therapeutix, Inc.
$24
Thea Pharma Inc.
$22
Carl Zeiss Meditec AG
$19
Top 3 companies account for 68.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ARGOS · ARTEVO 800 · AcrySof IQ PanOptix · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BESIVANCE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · Cequa · Clareon · DEXTENZA · DEXYCU · DUREZOL · DURYSTA · ENVISTA ENVY · Flarex · HYDRUS Microstent · IHEEZO · ILUX · INVELTYS · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX SM · LUMIGAN · MIEBO · MiSight Contact Lens · None Specified · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · ORA · OXERVATE · Omidria · Oxervate · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · Photrexa · Prokera · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · Rhopressa · Rocklatan · Simbrinza · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Symfony IOL · Tobradex ST · VEVYE · VUITY · VYZULTA · XDEMVY · XIIDRA · ZYLET · Zerviate · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for ophthalmology in NY.

Looking for an ophthalmology specialist in New Windsor?
Compare ophthalmologists in the New Windsor area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
75
Per 100K population
18.6
County median income
$96,497
Nearest hospital
MONTEFIORE ST LUKE'S CORNWALL
5.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Davidian is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Davidian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Davidian performed 453 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Davidian receive payments from pharmaceutical companies?
Yes. Dr. Davidian received a total of $36,375 from 45 companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Davidian's costs compare to other ophthalmologists in New Windsor?
Dr. Davidian's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Davidian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →